Pan-PPAR agonist IVA337 is an anti-fibrotic treatment with a unique mechanism of action going through the activation of all three alpha, gamma, and delta PPARs (pan-PPAR agonist)
There is also the rare chance of developing lactic acidosis, which can be life-threatening, and certain people taking metformin may have a risk of kidney damage
Patients allege they were never warned of a potential association between Ozempic and other GLP-1 drugs , rapid metabolic or blood pressure changes, and optic nerve injury, despite emerging reports and post-marketing safety signals
2016;11(5) doi: 10.1371/journal.pone.0154727
Its application in diabetes operates through a different pathway: it is thought to reset circadian rhythms in the hypothalamus, which regulate, among other things, daily blood glucose patterns (Shivaprasad & Kalra, 2011)
International Journal of Impotence Research, 30 (1), 2126